IS THE ALCOHOL CONSUMPTION THE RISK FACTOR FOR CHRONIC KIDNEY DISEASE?


Cite item

Full Text

Abstract

We have presented and have analyzed the data which confirm and deny the importance of regular alcohol consumption as a risk factor of chronic kidney disease.

About the authors

- -

References

  1. Мухин Н.А. Профилактическая нефрология и образ жизни современного человека // Терапевтический архив. 1993. № 6. С. 4-7.
  2. Смирнов А.В., Добронравов В.А., Каюков И.Г. Кардиоренальный континуум: патогенетические основы превентивной нефрологии // Нефрология и диализ. 2005. № 3. С. 7-15.
  3. Orth S.R. Smoking - a renal risk factor. Nephron 2000;86(1):12-26.
  4. Perneger T.V., Whelton P.K., Klag M.J. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1994;331(25):1675-1679.
  5. Chung C.H., Yang Y.H., Wang T.Y. et al. Oral precancerous disorders associated with areca quid chewing, smoking, and alcohol drinking in southern Taiwan. J. Oral. Pathol. Med. 2005;34(8):460-466.
  6. Chang W.C., Hsiao C.F., Chang H.Y. et al. Betel nut chewing and other risk factors associated with obesity among Taiwanese male adults. Int. J. Obes. (Lond.) 2006;30(2):359-363.
  7. Lin W.Y., Pi-Sunyer F.X., Liu C.S. et al. Betel nut chewing is strongly associated with general and central obesity in Chinese male middle-aged adults. Obesity (Silver Spring). 2009;17(6):1247-1254.
  8. Lin W.Y., Chiu T.Y., Lee L.T. et al. Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. Am. J. Clin. Nutr. 2008; 87(5): 1204-1211
  9. Chou C.Y., Cheng S.Y., Liu J.H. et al. Association between betel-nut chewing and chronic kidney disease in men. Public Health Nutr. 2009;12(5):723-727.
  10. Огурцов П.П., Нужный В.П. Экспресс-диагностика (скрининг) хронической алкогольной интоксикации у больных соматического профиля // Клиническая фармакология и терапия. 2001. № 1. С. 34-39.
  11. Моисеев В.С., Огурцов П.П. Алкогольная болезнь: патогенетические, диагностические и клинические аспекты // Терапевтический архив. 1997. № 12. С. 5-12.
  12. Talaie H., Pajouhmand A., Abdollahi M. et al. Rhabdomyolysis among acute human poisoning cases. Hum. Exp. Toxicol. 2007;26(7):557-561.
  13. Kraut J.A., Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis and management. Clin. J. Am. Soc. Nephrol. 2008;3:208-225.
  14. Мухин Н.А., Балкаров И.М. Подагрическая почка. В: Тареева И.Е. (ред.) Нефрология: руководство для врачей. М., 2000. С. 422-428.
  15. Лебедева М.В., Балкаров И.М., Шовская Т.Н. Острая уратная нефропатия - причина обратимой почечной недостаточности у молодого больного // Терапевтический архив. 2006. №78(5). С. 69-71.
  16. Domrongkitchaiporn S., Sritara P., Kitiyakara C. et al. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J. Am. Soc. Nephrol. 2005;16(3):791-799.
  17. Chen N., Wang W., Huang Y. et al. Community-based study on CKD subjects and the associated risk factors. Nephrol. Dial. Transplant. 2009;24(7):2117-2123.
  18. Borges R.L., Hirota A.H., Quinto B.M. et al. Uric acid as a marker for renal dysfunction in hypertensive women on diuretic and nondiuretic therapy. J. Clin. Hypertens. (Greenwich). 2009;11(5):253-259.
  19. Suliman M.E., Johnson R.J., García-Lopez E. et al. J-shaped mortality relationship for uric acid in CKD. Am. J. Kidney Dis. 2006;48(5):761-771.
  20. Kang D.-H., Nakagawa T., Feng L. et al. A role of uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 2002;13:2888-2897.
  21. Мухин Н.А., Шоничев Д.Г., Балкаров И.М. и соавт. Формирование артериальной гипертонии при уратном тубулоинтерстициальной поражении почек // Терапевтический архив. 1999. № 6. С. 12-24.
  22. Sanchez-Lozada L.G., Tapia E., Santamaría J. et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67(1):237-247.
  23. Choi H.K., Gurhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2004;51(6):1023-1029.
  24. Sugie T., Imatou T., Miyazaki M., Une H. The effect of alcoholic beverage type on hyperuricemia in Japanese male office workers. J. Epidemiol. 2005;15(2):41-47.
  25. Yu K.H., See L.C., Huang Y.C. et al. Dietary factors associated with hyperuricemia in adults. Semin. Arthritis Rheum. 2008;37(4):243-250.
  26. Shiraishi H., Une H. The effect of the interaction between obesity and drinking on hyperuricemia in Japanese male office workers. J. Epidemiol. 2009;19(1):12-16.
  27. Shankar A., Klein R., Klein B.E. The association among smoking, heavy drinking, and chronic kidney disease. Am. J. Epidemiol. 2006;164(3):263-271.
  28. Yamagata K., Ishida K., Sairenchi T. et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007;71(2):159-166.
  29. White S.L., Polkinghorne K.R., Cass A. et al. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol. Dial. Transplant. 2009; 24(8):2464-2472.
  30. Reynolds K., Gu D., Chen J. et al. Alcohol consumption and the risk of end-stage renal disease among Chinese men. Kidney Int. 2008;73(7):870-876.
  31. Perneger T.V., Whelton P.K., Puddey I.B., et al. Risk of end-stage renal disease associated with alcohol consumption. Am. J. Epidemiol. 1999;150(12):1275-1281.
  32. Peters H., Martini S., Woydt R. et al. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis. Am. J. Physiol. Renal. Physiol. 2003;284(5):F1105-F1114.
  33. Vasdev S., Ford C.A., Longerich L. et al. Antihypertensive effect of low ethanol intake in spontaneously hypertensive rats. Mol. Cell. Biochem. 1999;200(1-2):85-92.
  34. Vasdev S., Gill V., Parai S., et al. Low ethanol intake prevents salt-induced hypertension in WKY rats. Mol. Cell Biochem. 2006;287(1-2):53-60.
  35. Российское Медицинское Общество по Артериальной Гипертонии - Всероссийское Научное Общество Кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр.). М., 2008.
  36. Calhoun D.A., Jones D., Textor S. et al. Resistant hypertension: diagnosis, evaluation and teratment: A scientific statement form the American Heart Association professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510-e526.
  37. Tirapelli C.R., Legros E., Brochu I. et al. Chronic ethanol intake modulates vascular levels of endothelin-1 receptor and enhances the pressor response to endothelin-1 in anaesthetized rats. Br. J. Pharmacol. 2008;154(5):971-981.
  38. Tumlin J.P., Madaio M.P., Hennigar R. Idiopathic IgA nephropathy: pathogenesis, histopathology and therapeutic options. Clin. J. Am. Soc. Nephrol. 2004;2:1054-1061.
  39. Smith S.M., Yu G.S., Tsukamoto H. IgA nephropathy in alcohol abuse. An animal model. Lab. Invest. 1990;62(2):179-184.
  40. Smith S.M., Leaber R., Lefebre A. et al. Pathogenesis of IgA nephropathy in ethanol consumption: animal model and cell culture studies. Alcohol. 1993;10(6):477-480.
  41. Wakai K., Kawamura T., Matsuo S. et al. Risk factors for IgA nephropathy: a case-control study in Japan. Am. J. Kidney Dis. 1999;33(4):738-745.
  42. Wakai K., Nakai S., Matsuo S. et al. Risk factors for IgA nephropathy: a case-control study with incident cases in Japan. Nephron. 2002;90(1):16-23.
  43. Kaartinen K., Niemela O., Syrjanen J. et al. Alcohol consumption and kidney function in IgA glomerulonephritis. Nephron. Clin. Pract. 2009;112(2):c86-c93.
  44. Stefanovic V., Cukuranovic R., Miljkovic S. et al. Fifty years of Balkan endemic nephropathy: challenges of study using epidemiological method. Ren. Fail. 2009;31(5):409-418.
  45. Gueye A.S., Chelamcharla M., Baird B.C. et al. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol. Dial. Transplant. 2007;22(3):891-898.
  46. Hu J., Chen Y., Mao Y. et al.; Canadian Cancer Registries Epidemiology Research Group. Alcohol drinking and renal cell carcinoma in Canadian men and women. Cancer Detect. Prev. 2008;32(1):7-14.
  47. Caimi G., Carollo C., Lo Presti R. Chronic renal failure: oxidative stress, endothelial dysfunction and wine. Clin. Nephrol. 2004;62(5):331-335.
  48. Presti R.L., Carollo C., Caimi G. Wine consumption and renal diseases: new perspectives. Nutrition. 2007;23(7-8):598-602.
  49. Gooderham P.A., Gagnon R.F., Gill K. Attenuation of the alcohol preference of C57BL/6 mice during chronic renal failure. J. Lab. Clin. Med. 2004;143(5):292-300.
  50. Vamvakas S., Teschner M., Bahner U. et al. Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin. Nephrol. 1998;49(4):205-213.
  51. De Marchi S., Cecchin E., Basile A. et al. Renal tubular dysfunction in chronic alcohol abuse-effects of abstinence. N. Engl. J. Med. 1993;329(26):1927-1934.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download